Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo

• Prif Awduron: Guoliang Yin (Awdur), Hongyi Liang (Awdur), Wenxiu Sun (Awdur), Shizhao Zhang (Awdur), Yanan Feng (Awdur), Pengpeng Liang (Awdur), Suwen Chen (Awdur), Xiangyi Liu (Awdur), Wenchao Pan (Awdur), Fengxia Zhang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Our previous studies have found that Shuangyu Tiaozhi Decoction (SYTZD) could produce an improvement in NAFLD-related indicators, but the underlying mechanism associated with this improvement remain...